Nautilus Biotechnology, Inc.
NAUT
$0.6884
-$0.0246-3.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.59M | -16.45M | -18.01M | -18.73M | -17.02M |
| Total Depreciation and Amortization | 1.55M | 1.61M | 1.60M | 1.59M | 1.59M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.34M | 2.46M | 2.58M | 2.36M | 2.45M |
| Change in Net Operating Assets | -1.61M | -740.00K | -1.62M | -1.49M | -920.00K |
| Cash from Operations | -14.31M | -13.11M | -15.46M | -16.27M | -13.90M |
| Capital Expenditure | -1.01M | -709.00K | -512.00K | -647.00K | -413.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.12M | -6.79M | 14.81M | 23.00M | -40.65M |
| Cash from Investing | 37.11M | -7.50M | 14.29M | 22.35M | -41.06M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 440.00K | 140.00K | 319.00K | 245.00K | 253.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 440.00K | 140.00K | 319.00K | 245.00K | 253.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.24M | -20.48M | -844.00K | 6.33M | -54.71M |